NYSE:MMS - MAXIMUS Stock Price, Price Target & More

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

MAXIMUS declared a quarterly dividend on Thursday, July 12th. Stockholders of record on Wednesday, August 15th will be paid a dividend of $0.045 per share on Friday, August 31st. This represents a $0.18 annualized dividend and a dividend yield of 0.28%. The ex-dividend date is Tuesday, August 14th. View MAXIMUS's Dividend History.

MAXIMUS announced that its Board of Directors has authorized a stock repurchase plan on Monday, June 25th 2018, which authorizes the company to repurchase $200,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to purchase up to 4.9% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's leadership believes its stock is undervalued.

MAXIMUS, Inc. (NYSE:MMS) issued its quarterly earnings results on Thursday, May, 10th. The health services provider reported $0.82 EPS for the quarter, missing the consensus estimate of $0.84 by $0.02. The health services provider earned $612.79 million during the quarter, compared to the consensus estimate of $617.97 million. MAXIMUS had a net margin of 9.15% and a return on equity of 21.67%. The firm's quarterly revenue was down 1.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.80 earnings per share. View MAXIMUS's Earnings History.

MAXIMUS is scheduled to release their next quarterly earnings announcement on Thursday, August, 9th 2018. View Earnings Estimates for MAXIMUS.

MAXIMUS issued an update on its FY18 earnings guidance on Thursday, May, 10th. The company provided EPS guidance of $3.30-3.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.49. The company issued revenue guidance of $2.4-2.44 billion, compared to the consensus revenue estimate of $2.50 billion.

3 brokerages have issued 1-year target prices for MAXIMUS's shares. Their forecasts range from $64.00 to $81.00. On average, they expect MAXIMUS's stock price to reach $69.50 in the next twelve months. This suggests a possible upside of 6.7% from the stock's current price. View Analyst Ratings for MAXIMUS.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to MAXIMUS include Mercadolibre (MELI), Total System Services (TSS), Worldpay (WP), CoStar Group (CSGP), Msci (MSCI), Broadridge Financial Solutions (BR), Akamai Technologies (AKAM), Alliance Data Systems (ADS), CIELO S A/S (CIOXY), Zillow Group Inc Class A (ZG), Zillow Group Inc Class C (Z), Nielsen (NLSN), GrubHub (GRUB), The Western Union (WU) and CDK Global (CDK).

Press coverage about MMS stock has trended somewhat positive this week, Accern Sentiment reports. Accern scores the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. MAXIMUS earned a news impact score of 0.07 on Accern's scale. They also gave media headlines about the health services provider an impact score of 47.13 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term.

MAXIMUS's stock is owned by many different of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (1.55%), Handelsbanken Fonder AB (0.48%), Summit Creek Advisors LLC (0.25%), West Coast Financial LLC (0.14%), Contravisory Investment Management Inc. (0.11%) and Cambiar Investors LLC (0.11%). Company insiders that own MAXIMUS stock include Anne K Altman, Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni, Richard John Nadeau and Russell A Beliveau. View Institutional Ownership Trends for MAXIMUS.

MMS stock was sold by a variety of institutional investors in the last quarter, including Handelsbanken Fonder AB, Riverbridge Partners LLC, Summit Creek Advisors LLC, Clinton Group Inc., Municipal Employees Retirement System of Michigan, Bank of Montreal Can, West Coast Financial LLC and Contravisory Investment Management Inc.. Company insiders that have sold MAXIMUS company stock in the last year include Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Insider Buying and Selling for MAXIMUS.

MMS stock was purchased by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, Xact Kapitalforvaltning AB, Amalgamated Bank and Cim LLC. Company insiders that have bought MAXIMUS stock in the last two years include Anne K Altman and Richard John Nadeau. View Insider Buying and Selling for MAXIMUS.

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MMS stock can currently be purchased for approximately $65.15.

MAXIMUS has a market capitalization of $4.25 billion and generates $2.45 billion in revenue each year. The health services provider earns $209.42 million in net income (profit) each year or $3.03 on an earnings per share basis. MAXIMUS employs 20,400 workers across the globe.

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]